Compare GENB & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GENB | MD |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Hospital/Nursing Management |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2026 | 1996 |
| Metric | GENB | MD |
|---|---|---|
| Price | $16.29 | $26.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $23.20 | $20.50 |
| AVG Volume (30 Days) | ★ 1.3M | 774.9K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 263.03 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $1,913,849,000.00 |
| Revenue This Year | N/A | $3.72 |
| Revenue Next Year | $16.58 | $2.62 |
| P/E Ratio | ★ N/A | $31.60 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.00 | $15.70 |
| 52 Week High | $22.67 | $28.86 |
| Indicator | GENB | MD |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 55.94 |
| Support Level | $12.05 | $20.62 |
| Resistance Level | $17.46 | $27.23 |
| Average True Range (ATR) | 1.69 | 0.74 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 18.75 | 81.69 |
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.